"As COVID-19 converges with the flu, it is critical for physicians to be able to quickly differentiate between these viruses at the point of care, which present with nearly identical symptoms, in order to take appropriate clinical actions and maximize efficient use of healthcare resources," Chembio's vice president of sales and marketing, Charles Caso, said in a statement.